Andrew Arno, Director at Oncocyte Corp (OCX), bought 12,500 shares at $2.11 ($26K) on 2024-12-26, disclosed to the SEC on 2024-12-26.
Open-market purchase of $26k OCX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| OCX | BUY | 2022-12-28 | $88K | — | Filing → |
| SMSI | BUY | 2022-08-22 | $64K | — | Filing → |
| OCX | BUY | 2022-08-19 | $7K | — | Filing → |